1. Kidd M. Influenza viruses: update on epidemiology, clinical features, treatment and vaccination. Current opinion in pulmonary medicine. 2014;20(3):242-6.
2. Dou D, Revol R, Östbye H, Wang H, Daniels R. Influenza A virus cell entry, replication, virion assembly and movement. Frontiers in immunology. 2018;9:1581.
3. Kain T, Fowler R. Preparing intensive care for the next pandemic influenza. Critical care. 2019;23(1):337.
4. Nesmith N, Williams JV, Johnson M, Zhu Y, Griffin M, Talbot HK. Sensitive diagnostics confirm that influenza C is an uncommon cause of medically attended respiratory illness in adults. Clinical Infectious Diseases. 2017;65(6):1037-9.
5. Smith GJ, Bahl J, Vijaykrishna D, Zhang J, Poon LL, Chen H, et al. Dating the emergence of pandemic influenza viruses. Proceedings of the National Academy of Sciences. 2009;106(28):11709-12.
6. Viboud C, Simonsen L, Fuentes R, Flores J, Miller MA, Chowell G. Global mortality impact of the 1957–1959 influenza pandemic. The Journal of infectious diseases. 2016;213(5):738-45.
7. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. Journal of infectious diseases. 1998;178(1):53-60.
8. Somerville LK, Basile K, Dwyer DE, Kok J. The impact of influenza virus infection in pregnancy. Future microbiology. 2018;13(2):263-74.
9. Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35(4):521-8.
10. Control CfD, Prevention. Updated interim recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. H1N1flu/pregnancy/antiviral_messages htm. 2009.
11. Kalil AC, Thomas PG. Influenza virus-related critical illness: Pathophysiology and epidemiology. Critical Care. 2019;23(1):258.
12. Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Human reproduction update. 2016;22(1):116-33.
13. Picone O, Bernabe-Dupont C, Vauloup-Fellous C, Castel C, Cordier A, Guillet M, et al. A suspected case of in utero transmission of influenza A (H1N1) 2009. Journal de gynecologie, obstetrique et biologie de la reproduction. 2011;40(5):473.
14. Luteijn J, Brown M, Dolk H. Influenza and congenital anomalies: a systematic review and meta-analysis. Human reproduction. 2014;29(4):809-23.
15. Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction. 2004;128(2):139-46.
16. Saito S. Cytokine network at the feto-maternal interface. Journal of reproductive immunology. 2000;47(2):87-103.
17. Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, et al. Induction of regulatory T cells by physiological level estrogen. Journal of cellular physiology. 2008;214(2):456-64.
18. Piccinni M-P. T cell tolerance towards the fetal allograft. Journal of reproductive immunology. 2010;85(1):71-5.
19. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. American journal of reproductive immunology. 2010;63(6):425-33.
20. Carvalheiras G, Vita P, Marta S, Trovão R, Farinha F, Braga J, et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clinical reviews in allergy & immunology. 2010;38(2-3):302-6.
21. Varner MW, editor Autoimmune disorders and pregnancy. Seminars in perinatology; 1991.
22. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. International reviews of immunology. 2002;21(6):471-95.
23. Forbes RL, Gibson PG, Murphy VE, Wark PA. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax. 2012;67(3):209-14.
24. Kay AW, Bayless NL, Fukuyama J, Aziz N, Dekker CL, Mackey S, et al. Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine. The Journal of infectious diseases. 2015;212(6):861-70.
25. Cérbulo-Vázquez A, Figueroa-Damián R, Arriaga-Pizano LA, Hernández-Andrade E, Mancilla-Herrera I, Flores-Mejía LA, et al. Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS One. 2014;9(9):e107900.
26. Osterholm MT. Preparing for the next pandemic. New England Journal of Medicine. 2005;352(18):1839-42.
27. Ramsey PS, Ramin KD. Pneumonia in pregnancy. Obstetrics and gynecology clinics of North America. 2001;28(3):553-69.
28. PECK TM, ARIAS F. Hematologic changes associated with pregnancy. Clinical obstetrics and gynecology. 1979;22(4):785-98.
29. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiology and Molecular Biology Reviews. 2012;76(1):16-32.
30. Hussell T, Goulding J. Structured regulation of inflammation during respiratory viral infection. The Lancet infectious diseases. 2010;10(5):360-6.
31. Oldstone MB, Teijaro JR, Walsh KB, Rosen H. Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection. Virology. 2013;435(1):92-101.
32. Xi-zhi JG, Thomas PG, editors. New fronts emerge in the influenza cytokine storm. Seminars in immunopathology; 2017: Springer.
33. Turner SJ, Olivas E, Gutierrez A, Diaz G, Doherty PC. Disregulated influenza A virus-specific CD8+ T cell homeostasis in the absence of IFN-γ signaling. The Journal of Immunology. 2007;178(12):7616-22.
34. Saraiva M, O'garra A. The regulation of IL-10 production by immune cells. Nature reviews immunology. 2010;10(3):170-81.
35. Crook M, Constable S, Lumb P, Rymer J. Elevated serum sialic acid in pregnancy. Journal of clinical pathology. 1997;50(6):494-5.
36. Cusi MG. Letter to the Editor: Why is influenza virus more risky for pregnant women? Influenza and other respiratory viruses. 2010;4(5):247.
37. Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, et al. Prevention of influenza pneumonitis by sialic acid–conjugated dendritic polymers. The Journal of infectious diseases. 2002;186(9):1222-30.
38. Kahn KE, Black CL, Ding H, Williams WW, Lu P-J, Fiebelkorn AP, et al. Influenza and Tdap vaccination coverage among pregnant women—United States, April 2018. Morbidity and Mortality Weekly Report. 2018;67(38):1055.
39. McMillan M, Porritt K, Kralik D, Costi L, Marshall H. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015;33(18):2108-17.
40. Lindley MC, Kahn KE, Bardenheier BH, D’Angelo DV, Dawood FS, Fink RV, et al. Vital signs: burden and prevention of influenza and pertussis among pregnant women and infants—United States. Morbidity and Mortality Weekly Report. 2019;68(40):885.
41. Marshall H, McMillan M, Andrews R, Macartney K, Edwards K. Vaccines in pregnancy: the dual benefit for pregnant women and infants. Human Vaccines & Immunotherapeutics. 2016;12(4):848-56.
42. Diseases CoI. Recommendations for prevention and control of influenza in children, 2018–2019. Pediatrics. 2018;142(4).
43. Englund JA. Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine. 2003;21(24):3460-4.
44. Schlaudecker EP, Steinhoff MC, Omer SB, McNeal MM, Roy E, Arifeen SE, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PloS one. 2013;8(8):e70867.
45. Sylte MJ, Suarez DL. Influenza neuraminidase as a vaccine antigen. Vaccines for Pandemic Influenza. 2009:227-41.
46. Chan K-H, Zhang AJ, To KK, Chan CC, Poon VK, Guo K, et al. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS One. 2010;5(10):e13757.
47. Christian LM, Iams JD, Porter K, Glaser R. Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine. 2011;29(48):8982-7.
48. Schlaudecker EP, Ambroggio L, McNeal MM, Finkelman FD, Way SS. Declining responsiveness to influenza vaccination with progression of human pregnancy. Vaccine. 2018;36(31):4734-41.
49. Yates L, Pierce M, Stephens S, Mill A, Spark P, Kurinczuk J, et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess. 2010;14(34):109-82.
50. Yuen CYS, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women–a systematic review. Vaccine. 2014;32(36):4602-13.
51. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. The lancet Respiratory medicine. 2014;2(5):395-404.
52. Cantu J, Tita AT. Management of influenza in pregnancy. American journal of perinatology. 2013;30(02):099-104.
53. Hurt A, Hardie K, Wilson N, Deng Y-M, Osbourn M, Leang S, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A (H1N1) pdm09 influenza in Australia. The Journal of infectious diseases. 2012;206(2):148-57.
Pathobiology Reserach